PIK3AP1 (phosphoinositide-3-kinase adaptor protein 1) is a critical signaling adapter that bridges B-cell receptor (BCR) signaling to the PI3K-Akt pathway by providing a docking site for the regulatory PI3K subunit 1. Beyond BCR signaling, PIK3AP1 functions as a proximal Toll-like receptor (TLR) adaptor, coupling TLR activation to PI3K signaling while restraining excessive inflammatory responses 1. The protein also participates in natural killer cell activation and B-cell survival via REL activation [UniProt]. Mechanistically, PIK3AP1 regulates the PI3K/AKT signaling cascade; miR-1246 negatively regulates PIK3AP1 expression in thyroid cancer, with decreased PIK3AP1 reducing PI3K and AKT phosphorylation 2. PIK3AP1 expression is modulated by DNA methylation; H. pylori infection induces PIK3AP1 promoter hypermethylation and downregulation in gastric epithelial cells, leading to reduced IL-6 expression and altered immune responses 3. Clinically, PIK3AP1 dysregulation associates with multiple diseases: differential methylation occurs in autoinflammatory PFAPA syndrome 4, elevated circulating PIK3AP1 correlates with increased endometrial cancer risk 5, and altered PIK3AP1 expression in neutrophils and fibroblasts participates in preeclampsia and periodontitis pathogenesis 6. Aberrant PIK3AP1-containing gene pairs emerge as sepsis biomarkers 7, highlighting its importance in immune homeostasis across multiple pathological contexts.